Skip to main content
Clinical Trials/IRCT20220222054093N1
IRCT20220222054093N1
Recruiting
Phase 3

Evaluating efficacy and safety of topical and intravenous tranexamicacid for reducing peri/postoperative blood loss in primary Total knee arthroplasty

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Reduction of bleeding during knee replacement surgery among subjects receiving intravenous and intra-articular tranexamic acid and subjects receiving intra-articular only..
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with severe knee osteoarthritis whose pain is not controlled by drug treatment and are candidates for joint replacement.

Exclusion Criteria

  • Patients who have contraindications to receive tranexamic acid

Outcomes

Primary Outcomes

Not specified

Similar Trials